| CYSB2400223 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2024-08-21 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2400222 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2024-08-21 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2400043 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(原7) | Supplementary Application | 2024-02-20 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2300147 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2023-07-28 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2300115 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(原7) | Supplementary Application | 2023-06-14 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2300046 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2023-02-22 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2300047 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2023-02-22 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2200002 | 狂犬病人免疫球蛋白 | human rabies immunoglobulin | Injection | Biological Products(原15) | Supplementary Application | 2022-01-05 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2200001 | 狂犬病人免疫球蛋白 | human rabies immunoglobulin | Injection | Biological Products(原15) | Supplementary Application | 2022-01-05 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2200003 | 狂犬病人免疫球蛋白 | human rabies immunoglobulin | Injection | Biological Products(原15) | Supplementary Application | 2022-01-05 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CXSS2101053 | 人抗凝血酶Ⅲ | | Other | Biological Products(3.2) | New Drug Application | 2021-11-19 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CXSL2101301 | 人凝血因子Ⅷ/血管性血友病因子复合物 | | Lyophilized | Biological Products(3.2) | New Drug Application | 2021-09-02 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CXSL2101300 | 人凝血因子Ⅷ/血管性血友病因子复合物 | | Lyophilized | Biological Products(3.2) | New Drug Application | 2021-09-02 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2101003 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-03-06 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2101002 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-03-06 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2100042 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2021-02-23 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | In Review | 2022-01-27 | view |
| CYSB2100041 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2021-02-23 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | In Review | 2022-01-27 | view |
| CYSB2100025 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products(原15) | Supplementary Application | 2021-02-23 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | In Review | 2022-01-27 | view |
| CYSB2101000 | 破伤风人免疫球蛋白 | human tetanus immunoglobulin | Injection | Biological Products(原15) | Supplementary Application | 2021-02-18 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2100054 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(原7) | Supplementary Application | 2021-02-05 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | In Review | 2022-01-25 | view |
